CLINICAL IMPACT OF DRUG-DRUG INTERACTIONS: CONSIDERATION OF ETHNIC AND OTHER PATIENT FACTORS

被引：0
|
作者：
Huang, Shiew Mei [1 ]
机构：
[1] US FDA, CDER, Off Clin Pharmacol, Silver Spring, MD USA
来源：
DRUG METABOLISM REVIEWS | 2015年 / 47卷
关键词：
D O I：
10.3109/03602532.2015.1071938
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
SC1.3
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [1] Drug-Drug Interactions with Consideration of Pharmacogenetics
    Ozawa, Shogo
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2018, 138 (03): : 365 - 371
  • [2] Clinical impact of drug-drug interactions with systemic azole antifungals
    Bates, DW
    Yu, DT
    DRUGS OF TODAY, 2003, 39 (10): : 801 - 813
  • [3] Drug-drug interactions in clinical practice
    Depont, Fanny
    Vargas, Frederic
    Dutronc, Herve
    Giauque, Emmanuelle
    Ragnaud, Jean-Marie
    Galperine, Tatiana
    Abouelfath, Abdelilah
    Valentino, Ruddy
    Dupon, Michel
    Hebert, Guillaume
    Moore, Nicholas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (11) : 1227 - 1233
  • [4] DRUG-DRUG INTERACTIONS WITH CIPROFLOXACIN AND OTHER FLUOROQUINOLONES
    POLK, RE
    AMERICAN JOURNAL OF MEDICINE, 1989, 87 (5A): : S76 - S81
  • [5] Real clinical impact of drug-drug interactions of immunosuppressants in transplant patients
    Isabel Gago-Sanchez, Ana
    Font, Pilar
    Cardenas, Manuel
    Dolores Aumente, Maria
    Ramon Del Prado, Jose
    Angel Calleja, Miguel
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (06):
  • [6] Treatment of Ocular Infections: Consideration for Antibiotic Drug-Drug Interactions
    Wozniak, Rachel
    Johnson, William
    Dunster, Elianna
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [7] Improving the Working Models for Drug-Drug Interactions: Impact on Preclinical and Clinical Drug Development
    Nguyen, James
    Joseph, David
    Chen, Xin
    Armanios, Beshoy
    Sharma, Ashish
    Stopfer, Peter
    Huang, Fenglei
    PHARMACEUTICS, 2025, 17 (02)
  • [8] Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice
    Huang, S-M
    Temple, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (03) : 287 - 294
  • [9] The impact of metabolic pathways to drug-drug interactions
    Wittmann, M.
    Koestlbacher, A.
    Hader, A.
    Koeber, R.
    Haen, E.
    PHARMACOPSYCHIATRY, 2011, 44 (06)
  • [10] SILDENAFIL AND FUROSEMIDE ASSOCIATED OTOTOXICITY: CONSIDERATION OF DRUG-DRUG INTERACTIONS, SYNERGY, AND BROADER CLINICAL RELEVANCE
    Skeith, Leslie
    Yamashita, Cory
    Mehta, Sanjay
    Farquhar, Donald
    Kim, Richard B.
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2013, 20 (02): : E128 - E131
12345